Navigation Links
'Seena' clinical trials named for pancreatic cancer advocate
Date:12/1/2011

PHOENIX, Ariz. -- A son's passion to find a cure for the cancer that claimed the life of his mother has led to a new series of clinical trials under a Translational Genomics Research Institute (TGen) initiative to find a cure for pancreatic cancer.

The 'Seena I' clinical trial is named for Seena Magowitz, a cancer research advocate and patient who fell victim to pancreatic cancer the nation's fourth leading cause of cancer death.

Pancreatic cancer patients can soon enroll in Seena I, which is planned for at least four clinical sites across the nation, including Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare.

The Pancreatic Cancer Research Team (PCRT) will supervise the Seena trials. PCRT is a worldwide consortium of 45 clinical institutions led by TGen and dedicated to finding a cure for pancreatic cancer.

For nearly a decade, Scottsdale resident Roger Magowitz has championed research into finding a cure for pancreatic cancer, a disease that took the life of his mother, Seena, in 2001.

"I am deeply honored and filled with tremendous hope that the clinical trials named for my mother, Seena, will lead perhaps within just a few years to an actual cure for pancreatic cancer," said Roger Magowitz, President of the Seena Magowitz Foundation, who has donated $1 million to the TGen pancreatic cancer initiative.

The pancreas is a gland behind the stomach that secretes enzymes into the upper part of the small intestine to help digestion. It also produces hormones, including insulin, which helps regulate the metabolism of sugars.

The Seena I trial consists of three treatment components:

  • The first treatment will be with gemcitabine and nab-paclitaxel (Abraxane) for a maximum of 6 months.
  • The next treatment is with a combination of four drugs: 5-FU (fluoruracil); Leucovorin; Oxaliplatin; and Irinotecan. This combination is called FOLFIRINOX, an acronym of
    '/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. Vaccine targeting latent TB enters clinical testing
2. Clinical trial for muscular dystrophy demonstrates safety of customized gene therapy
3. BI-Clinical Offers 100% Coverage of All ACO Quality Measures Released by CMS
4. Heart rate recovery predicts clinical worsening in pulmonary hypertension
5. Worlds first stem cell bandage in human clinical trials
6. Combination therapy shows potent tumor growth inhibition in preclinical studies
7. CBIs Interactive Response Technologies for Clinical Trials - the Only IVR/IWR Event of Its Kind - Will Be in Philadelphia on November 14-15, 2011
8. Study shows that new DNA test to identify Down syndrome in pregnancy is ready for clinical use
9. Professor Peter J. Coffeys stem cell therapy for Age-Related Macular Degeneration expected to begin clinical trials in 2012
10. AMIA advises FDA on clinical decision support
11. Reports highlight the evolving role of clinical microbiology laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... in pharmacies and health stores, phosphatidylserine is a ... soy. Proven to improve cognition and slow memory ... experiencing memory impairment. Now a team headed by ... Tel Aviv University,s Department of Human Molecular ... improves the functioning of genes involved in degenerative ...
(Date:5/21/2013)... battle? Try staying fit in space, where living quarters ... , That,s the challenge a group of Michigan State ... million grant from NASA. Their goal is to keep ... "You could give astronauts the best exercise regimen there ... to it, it isn,t going to help," said project ...
(Date:5/21/2013)... -- Over the past few decades, scientists have developed ... balloons and metallic stents. While generally effective, each of ... effects. , A new study from MIT analyzes the ... benefits of angioplasty balloons and drug-releasing stents, but may ... is inflated in the artery for only a brief ...
Breaking Biology News(10 mins):Common food supplement fights degenerative brain disorders 2Fueling fitness on the final frontier 2Evaluating a new way to open clogged arteries 2Evaluating a new way to open clogged arteries 3
... The International Council for Science (ICSU), within ... major 10-year initiative which aims to effectively deliver ... This new international collaboration effort, the Earth System ... to respond to the most pressing societal and ...
... typically search for their female partners. The mystery is that ... A new study of katydids in the latest issue ... by U of T Mississauga professor Darryl Gwynne-- supports a theory ... just sperm. "In this beast [in this study], it,s ...
... Eliza Hall Institute have for the first time identified ... could one day lead to new treatments for one ... Dr Erinna Lee and Dr Doug Fairlie from the ... called apoptosis) in human cells. They have recently started ...
Cached Biology News:Research solutions for sustainability in a rapidly changing world 2Sexy snacks 2Worm 'cell death' discovery could lead to new drugs for deadly parasite 2
(Date:5/21/2013)... 21, 2013 As the R&D ... push within the industry to deliver better products, ... and pharma companies often means turning big ideas ... developed in collaboration with Sensidose AB and Recipharm, ... bring products to market sooner. The partnership resulted ...
(Date:5/21/2013)... May 21, 2013  Synthetic Biologics, Inc. (NYSE MKT: SYN), ... of serious infectious diseases, announced today that Jeffrey ... Annual Marcum LLP MicroCap Conference on Thursday, May 30, ... the Grand Hyatt Hotel. Mr. Riley is scheduled to present ... of Synthetic Biologics, presentation can be accessed by logging onto ...
(Date:5/21/2013)... NANONEX CORPORATION, a pioneer and ... announced the successful delivery and installation of a ... to a major Japanese manufacturing company. ... advanced nanoimprint lithography tool that has the ability ... sizes and types. Based on Nanonex inventions and ...
(Date:5/21/2013)... SoundConnect is pleased to announce the ... customers in Canada. Lync is the next generation ... businesses and organizations to collaborate and communicate much more ... in the United States. With the progressive rollout of ... in Canada, SoundConnect now offers a complete Microsoft Lync ...
Breaking Biology Technology:The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference 2Nanonex Announces the Shipment and Installation of an Innovative Nanoimprint Lithography System for Fully Automated Manufacturing 2SoundConnect Announces Microsoft Lync Release in Canada 2SoundConnect Announces Microsoft Lync Release in Canada 3
... ROCKVILLE, Md., May 17, 2011 Goodwin Biotechnology, Inc. ... Inc., a leader in cell line engineering for protein ... agreement for cell line engineering and biological contract manufacturing. ... of patients with inherited and acquired diseases," said Sung ...
... 2011 Magellan Biosciences, a global manufacturer of products ... less labor intensive, announced that its Vice President of ... a featured speaker at the Medicaid Health Plans of ... which takes place tomorrow in Washington, DC. Mr. De ...
... China Botanic Pharmaceutical Inc. (NYSE AMEX: ... developer, manufacturer and distributor of botanical products, bio-pharmaceuticals ... announced that the Company successfully showcased its all-natural ... recently held in Chengdu, China. ...
Cached Biology Technology:Goodwin Biotechnology and RAFAGEN Announce a Collaboration 2Magellan Biosciences to Present at Medicaid Health Plans of America Center for Best Practices First Annual Awards Forum 2Magellan Biosciences to Present at Medicaid Health Plans of America Center for Best Practices First Annual Awards Forum 3Magellan Biosciences to Present at Medicaid Health Plans of America Center for Best Practices First Annual Awards Forum 4Magellan Biosciences to Present at Medicaid Health Plans of America Center for Best Practices First Annual Awards Forum 5Magellan Biosciences to Present at Medicaid Health Plans of America Center for Best Practices First Annual Awards Forum 6China Botanic Exhibits All-Natural Products at the 65th PHARMACHINA Fair 2China Botanic Exhibits All-Natural Products at the 65th PHARMACHINA Fair 3
Formulation: Phosphate-buffered saline, pH 7.2, containing 0.09% sodium azide....
Mouse monoclonal [0.T.81] to Lac1 ( Abpromise for all tested applications). Antigen: Recombinant TrpE fusion protein containing full length E. coli Lac1....
Polyclonal Antibody to HADHB...
EDG-6 Lysate Source: Cell Lysate Application: Western Blotting Control Form: IgG...
Biology Products: